Testosterone treatment for boys with Klinefelter syndrome during puberty
Official title: Klinefelter Syndrome - the Effect of Testosterone Treatment in Puberty. a Randomized, Double-blind Placebo-controlled Intervention Study: 'The TiPY Study'
Run by Copenhagen University Hospital, Rigshospitalet · NCT06294990 · Data updated 2026-11-12
This study tests if giving testosterone gel to boys aged 10-14 with Klinefelter syndrome can help improve their growth, body health, and brain development during puberty.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 10 Years to 14 Years |
| Sex | Men only |
| Enrollment | 32 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | August 15, 2024 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | February 19, 2025 |
| Trial ID | NCT06294990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are boys aged 10-14 diagnosed with Klinefelter syndrome and exhibiting specific hormonal profiles.
✕Probably not a fit
Patients with contraindications to testosterone treatment or those currently participating in other clinical trials may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of testosterone replacement therapy on boys aged 10-14 with Klinefelter syndrome (KS, 47,XXY). Participants will be randomly assigned to receive either testosterone gel or a placebo for two years. The study aims to assess how testosterone treatment influences body fat, metabolism, growth, bone health, and neurocognitive development. The findings could provide critical insights into the management of KS during a crucial developmental period.
Why it matters
Potential benefit: If successful, this treatment could significantly improve health outcomes and quality of life for boys with Klinefelter syndrome.
How similar studies have gone: While testosterone treatment in puberty for Klinefelter syndrome has been debated, this study aims to provide much-needed evidence, as similar approaches have not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 47,XXY Klinefelter syndrome * Age 10-14 years at inclusion * Luteinizing Hormone \> +2 standard deviations (SD) by ultrasensitive luteinizing hormone assay * Free Testosterone\<+2 standard deviations * Signed consent from parents Exclusion Criteria: * Previous or ongoing T treatment except for TRT because of micropenis * Contraindications to testosterone treatment known hypersensitivity to testosterone or to any other constituent of the gel known or suspected prostatic cancer or breast carcinoma * Participation in any other clinical trial
Where it's running
-
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Lise Aksglaede, MD — Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- Study coordinator: Lise Aksglaede, MD
- Email: lise.aksglaede@regionh.dk
- Phone: +45 35455064
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balancing sex hormones to improve health in men with Klinefelter syndrome
This study is testing if a new hormone treatment can improve health and sperm production in men with Klinefelter syndrome by balancing their sex hormones and looking at weight loss effects.
-
Evaluating thyroid function and structure in Klinefelter syndrome
This study is testing how well the thyroid works and looks in people with Klinefelter syndrome compared to healthy individuals and those with a specific thyroid condition.
-
Research on health and development in infants with sex chromosome trisomy
This study looks at the health and development of infants with sex chromosome trisomies, like Klinefelter syndrome, to see how they grow and what early signs can help doctors provide better care.
-
Observing the health management of patients with rare genetic syndromes
This study looks at how patients with rare genetic syndromes like Prader-Willi and Klinefelter manage their health as they move from children's care to adult care to see what support they need.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.